Search
for
Sort by
Research 481–510 of 930
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Kisspeptin and LH pulsatile temporal coupling in PCOS patients
- Nonclassic Congenital Adrenal Hyperplasia
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Mood disorders and quality of life in polycystic ovary syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- Interventions for female pattern hair loss
- Androgens in women
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- Nonclassic congenital adrenal hyperplasia
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19